Follow-The-Filings

Holders · period archive

MIRM · Mirum Pharmaceuticals Inc.

Q4 2023 13F holders among managers we track latest ownership dossier

Ticker
MIRM
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares